Attached files
file | filename |
---|---|
8-K/A - UV FLU TECHNOLOGIES INC | v210450_8ka.htm |
EX-99.1 - UV FLU TECHNOLOGIES INC | v210450_ex99-1.htm |
Pro
forma financial statements
The
unaudited pro forma consolidated balance sheet and statement of operations for
the year ended September 30, 2010 combine the historical results of UV Flu
Technologies, Inc. and the audited results of RxAir Industries, LLC and gives
effect to the acquisition as if it occurred on October 1, 2009. Pro forma adjustments have
been made. The pro forma consolidated results do not purport to be indicative of
results that would have occurred had the acquisition been in effect for the
periods presented, nor do they claim to be indicative of the results that will
be obtained in the future, and do not include any adjustments for cost savings
or other synergies achieved in the consolidations of the companies.
RxAir
Industries, LLC was started on September 9, 2009 and had only 21 days of minimal
operations for the year ended September 30, 2009. Therefore, The proforma
consolidated balance sheet and statement of operations would be the materially
the same as the balance sheet and statement of operations of UV Flu Technologies
as of and for the year ended September 30, 2009.
UV
Flu Technologies, Inc.
Balance
Sheets
September
30, 2010
UVFT
|
RxAir
|
Eliminations
|
Pro
Forma
|
|||||||||||||
Assets
|
||||||||||||||||
Current
assets:
|
||||||||||||||||
Cash
|
$ | - | $ | 5,177 | $ | - | $ | 5,177 | ||||||||
Accounts
receivable
|
7,404 | 3,946 | - | 11,350 | ||||||||||||
Prepaid
expenses
|
95,908 | - | - | 95,908 | ||||||||||||
Inventory
|
66,815 | 45,886 | - | 112,701 | ||||||||||||
Total
current assets
|
170,127 | 55,009 | - | 225,136 | ||||||||||||
Fixed
assets, net of accumulated depreciation of $627
|
- | 2,420 | - | 2,420 | ||||||||||||
Other
assets:
|
||||||||||||||||
Deposits
|
- | 4,380 | - | 4,380 | ||||||||||||
Trademark
|
- | 950 | - | 950 | ||||||||||||
Total
other assets
|
- | 5,330 | - | 5,330 | ||||||||||||
- | ||||||||||||||||
Total
Assets
|
$ | 170,127 | $ | 62,759 | $ | - | $ | 232,886 | ||||||||
Liabilities
and Stockholders' Equity
|
||||||||||||||||
Current
liabilities
|
||||||||||||||||
Accounts
payable and accrued expenses
|
$ | 149,775 | $ | 36,090 | $ | - | $ | 185,865 | ||||||||
Note
payable
|
541,864 | 16,879 | - | 558,743 | ||||||||||||
Total
current liabilities
|
691,639 | 52,969 | - | 744,608 | ||||||||||||
- | ||||||||||||||||
Long
term debt
|
- | 16,382 | - | 16,382 | ||||||||||||
Commitments
and contingencies:
|
||||||||||||||||
Stockholders'
equity:
|
||||||||||||||||
Common
stock, $0.001 par value, 75,000,000 shares authorized, 45,080,000 shares
issued and outstanding
|
45,080 | - | 45,080 | |||||||||||||
Additional
paid-in capital
|
128,420 | 100 | 128,520 | |||||||||||||
Accumulated
(deficit)
|
(695,012 | ) | (6,692 | ) | (701,704 | ) | ||||||||||
Total
stockholders' equity
|
(521,512 | ) | (6,592 | ) | - | (528,104 | ) | |||||||||
- | ||||||||||||||||
Total
Liabilities and Stockholders' Equity
|
$ | 170,127 | $ | 62,759 | $ | - | $ | 232,886 |
UV
Flu Technologies, Inc.
Statements
of Operations
For
the Year Ended September 30, 2010
UVFT
|
RxAir
|
Eliminations
|
Proforma
|
|||||||||||||
Revenue
|
$ | 107,703 | $ | 171,743 | $ | - | $ | 279,446 | ||||||||
Cost
of Sales
|
85,582 | 29,179 | - | 114,761 | ||||||||||||
Gross
profit
|
22,121 | 142,564 | - | 164,685 | ||||||||||||
Expenses:
|
||||||||||||||||
General
and administrative
|
566,728 | 147,579 | - | 714,307 | ||||||||||||
Total
expenses
|
566,728 | 147,579 | - | 714,307 | ||||||||||||
Net
operating (loss)
|
(544,607 | ) | (5,015 | ) | - | (549,622 | ) | |||||||||
Other
income (expense):
|
||||||||||||||||
Interest
expense
|
(22,659 | ) | (1,677 | ) | - | (24,336 | ) | |||||||||
Gain
on sale of assets
|
1,116 | - | - | 1,116 | ||||||||||||
Other
|
(3 | ) | - | - | (3 | ) | ||||||||||
Total
other income (expense)
|
(21,546 | ) | (1,677 | ) | - | (23,223 | ) | |||||||||
Total
loss
|
$ | (566,153 | ) | $ | (6,692 | ) | $ | - | $ | (572,845 | ) |